Richard H. White, M.D.
- Chief of General Medicine
- Professor of Medicine
Richard H. White's two major areas of interest are anticoagulation therapy and rheumatology. He directs the UC Davis Anticoagulation Service and treats patients with deep-vein thrombosis, pulmonary embolism and other conditions requiring oral anticoagulant therapy. He also is interested in osteoarthritis, rheumatoid arthritis and other arthritic conditions. His study of the pharmacology of anticoagulants and epidemiology of venous thrombosis has generated more than a dozen research papers.
M.D., Washington University School of Medicine, St. Louis, Missouri, 1973
B.A., UC Santa Barbara, Santa Barbara, California, 1968
University of California, San Francisco, San Francisco, California, 1973-1975
University of California, San Francisco, San Francisco, California, 1976-1979
American Board of Internal Medicine, 1976
American Board of Internal Medicine, Rheumatology, 1980
American College of Physicians
American College of Rheumatology
Society for General Internal Medicine
Honors and Awards
Outstanding Clinical Instructor, 1991
Outstanding Faculty Teacher, 1982
Select Recent Publications
White RH, Gosselin RC. Testing for thrombophilia: pitfalls, limitations, and marginal impact on treatment duration recommendations. Mt Sinai J Med. 2009 Jun; 76:303-13.
White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009; 123 Supp14:S11-7.
White RH, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Utter GH, Geppert JJ, Romano PS. How Valid is the ICD-9-CM Based AHRQ Patient Safety Indicator for Postoperative Venous Thromboembolism? Med Care. 2009 Sep 25.
White RH. Cancer begets venous thromboembolism, but is venous thromboembolism a risk factor for cancer? J Thromb Haemost. 2009 Apr; 7:543-5.
Wun T, White RH. Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol. 2009 Mar; 22:9-23.
White RH, Zhou H, Murin S. Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism. Thromb Haemost. 2008 Apr; 99:683-90.
Chew HK, Davies AM, Wun T, Harvey D, Zhou B, White RH. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost. 2008 Apr; 6:601-8.
Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008 Aug 26; 179:417-26.
White RH, Chan WS, Zhou H, Ginsberg JS. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thromb Haemost. 2008 Aug; 100:246-52.
Semrad TJ, O'Donnell R, Wun T, Chew H, Harvey D, Zhou H, White RH. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg. 2007 Apr; 106:601-8.
White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost. 2006 Sep; 96:267 -73.
Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006 Mar 1; 24:1112-8.
White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005 Feb; 93:298-305.